1. EANM Radiopharmacy Committee (2007) guidelines on current good radiopharmacy practice (CGRPP) in the preparation of radiopharmaceuticals. http://www.eanm.org/scientific_info/guidelines/gl_radioph_cgrpp.pdf .
2. Pharmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme: PIC/S guide to good practices for preparation of medicinal products in healthcare establishments—PE 010-1 (19 November 2007; into force on April 1 2008). http://www.picscheme.org/index.php?p=guides .
3. Maintenance of the ICH guideline on non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals M3(R1). http://www.ich.org/cache/compo/502-272-1.html#M3 .
4. Detailed guidance for the request for authorisation of a clinical trial on a medicinal product for human use to the competent authorities. ENTR/F2/BL D(2003). http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-10/11_ca_14-2005.pdf .
5. Guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials. CHMP/QWP/185401/2004 final. http://www.emea.europa.eu/pdfs/human/qwp/18540104en.pdf .